Cite
HARVARD Citation
Galván-Femenía, I. et al. (2018). Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2. Cancer treatment and research communications. pp. 21-31. [Online].